Labeling strategies of selected subtypes of the hexahydronaphth[2,3-b]-1,4- oxazine- and octahydrobenzo[g]quinoline-type

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 50, Issue 5-6, 2007, Pages 616-619

  Moenius, Thomas ^a   Andres, Hendrik ^a   Nozulak, Joachim ^a   Salter, Rhys ^a   Ray, Tapan ^a   Burtscher, Paul ^a   Schnelli, Peter ^a   Züger, Christoph ^a   Voges, Rolf ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Labeling; Quinoline type; Schwartz' reagent

Indexed keywords

LABELING STRATEGY; LABELINGS; QUINOLINE-TYPE; SCHWARTZ' REAGENT;

HEXAHYDRONAPHTH[2,3B] 1,4 OXAZINE; OCTAHYDROBENZO[G]QUINOLINE; OXAZINE DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL REACTION; CONFERENCE PAPER; ISOTOPE LABELING; STEREOCHEMISTRY; SYNTHESIS;

EID: 34548153751     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1310     Document Type: Conference Paper

References (7)

1. (a) Renaud A, Nishino S, Dement WC, Guilleminault C, Mignot E. Eur J Pharmacol 1991; 205: 11-16;
2. (b) Nozulak J, Vigouret JM, Jaton AL, Hofmann A, Dravid AR, Weber HP, Kalkmann HO, Walkinshaw MD. J Med Chem 1992; 35: 480-489;
3. (c) Eltze M, Boer R. Eur J Pharmacol 1992; 224: 125-136.
4. (a) Zippi EM, Andres H, Morimoto H, Williams PG. Synth Commun 1994; 24(7): 1037;
5. (b) Godfrey AG, Ganem B. Tetrahedron Lett 1992; 33(49): 7461.
6. Wiegand HJ. Novartis Pharma internal communication, 2001.
7. Bänziger M, Küsters E, La Vecchia L, Marterer W, Nozulak J. Org Process Res Dev 2003; 7: 904.